Medtronic plc (MDT) recently presented positive clinical trial safety and efficacy results for Sphere-360 -- an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy The catheter is intended for treatment of patients with paroxysmal atrial fibrillation (AFib).The European Heart Rhythm Association (EHRA) 2024 Annual Meeting featured a late-breaking clinical trial showcasing interim findings from the first-in-human Sphere-360 investigation.About Sphere-360 CatheterThe Sphere ...